Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. News
  7. Summary
    SAN   FR0000120578

SANOFI

(SAN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SANOFI : Receives a Buy rating from Kepler Cheuvreux

12/02/2021 | 07:32am EST

Kepler Cheuvreux is positive on the stock with a Buy rating. The target price remains unchanged at EUR 105.


ę MarketScreener with dpa-AFX Analyser 2021
All news about SANOFI
01/20Exclusive-Polish drug maker Polpharma working on bid for Advent's Zentiva - sources
RE
01/19Regeneron Says FDA to Review Libtayo/Chemotherapy Combo in First-Line NSCLC Treatment
DJ
01/19Sanofi, Regeneron Say Dupixent Significantly Reduces Itching in Prurigo Nodularis Patie..
MT
01/19Sanofi-Regeneron's Dermatitis Drug Lowers Itch, Skin Lesions In Late-Stage Trial
MT
01/19Sanofi Announces Second Positive Phase 3 Dupixent« Trial Confirms Significant Improveme..
CI
01/17Factbox-GSK's consumer healthcare business coveted by Unilever
RE
01/15Factbox-GSK's consumer health business
RE
01/15GSK rejects 50-billion-pound Unilever offer for consumer assets
RE
01/14SANOFI : Déclaration des transactions sur actions propres
PU
01/13Sanofi India's Managing Director to Step Down in April
MT
More news
Analyst Recommendations on SANOFI
More recommendations
Financials
Sales 2021 37 730 M 42 737 M 42 737 M
Net income 2021 6 134 M 6 948 M 6 948 M
Net Debt 2021 10 144 M 11 490 M 11 490 M
P/E ratio 2021 19,1x
Yield 2021 3,55%
Capitalization 117 B 132 B 132 B
EV / Sales 2021 3,36x
EV / Sales 2022 3,09x
Nbr of Employees 99 412
Free-Float 88,4%
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 92,92 €
Average target price 106,75 €
Spread / Average Target 14,9%
EPS Revisions
Managers and Directors
Paul Hudson Chief Executive Officer & Director
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
Serge Weinberg Director
John C. Reed EVP & Global Head-Research & Development
Nestle Frank Global Head-Immunology Therapeutic Research Area
Sector and Competitors
1st jan.Capi. (M$)
SANOFI4.90%132 264
JOHNSON & JOHNSON-3.40%435 037
ROCHE HOLDING AG-3.69%322 260
PFIZER, INC.-8.47%303 375
ABBVIE INC.-1.75%235 181
NOVO NORDISK A/S-13.40%220 833